The glycosphingolipid inhibitor eliglustat inhibits autophagy in osteoclasts to increase bone mass and reduce myeloma bone disease

JSON

Leng H, Zhang H, Li L, Zhang S, Wang Y, Ersek A, Morris E, Sezgin E, Lee YH, Li Y, Mi J, Zhong Q, Edwards C, Simon AK, Horwood NJ

- - (-) - [2021-02-06; online 2021-02-06]

Erdinc Sezgin

SciLifeLab Fellow

DOI 10.1101/2021.02.05.429906

Crossref 10.1101/2021.02.05.429906